Evidence map›Paper›PMID 37744103›Full record

SynthesisFrontiers in fungal biology2021

Bioprospecting

Tomás A Rush, Him K Shrestha, Muralikrishnan Gopalakrishnan Meena, Margaret K Spangler, J Christopher Ellis, Jesse L Labbé, Paul E Abraham

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in fungal biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. EngineeringAIMS microbiology · 2026
    Review
  6. Review
  7. Article
  8. Exploring the Bioactive Secondary Metabolites of Two ArgentineJournal of fungi (Basel, Switzerland) · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Genomic Based Analysis of the Biocontrol SpeciesJournal of fungi (Basel, Switzerland) · 2023
    Article
  15. Solid-State Fermentation ofJournal of agricultural and food chemistry · 2023
    Article
  16. Strain improvement ofFrontiers in microbiology · 2023
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tomás A RushOak Ridge National Laboratory, Biosciences Division, Oak Ridge, TN, United States.
Him K ShresthaOak Ridge National Laboratory, Biosciences Division, Oak Ridge, TN, United States.
Muralikrishnan Gopalakrishnan MeenaOak Ridge National Laboratory, National Center for Computational Sciences, Oak Ridge, TN, United States.
Margaret K SpanglerOak Ridge National Laboratory, Biosciences Division, Oak Ridge, TN, United States.
J Christopher EllisOak Ridge National Laboratory, Biosciences Division, Oak Ridge, TN, United States.
Jesse L LabbéOak Ridge National Laboratory, Biosciences Division, Oak Ridge, TN, United States.
Paul E AbrahamOak Ridge National Laboratory, Biosciences Division, Oak Ridge, TN, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural products derived from microbes are crucial innovations that would help in reaching sustainability development goals worldwide while achieving bioeconomic growth.

Indexed as

antimicrobialsdrug discoveriesfunctional genomicsgraph theory—graph algorithmsintegrated pest managementplant-microbe interactionspredictive biologysecondary metabolites

Identifiers

PMID37744103
PMCPMC10512312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.